| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Impurity D |
非奈利酮雜質(zhì)D |
2640280-83-5 |
詳細(xì)
|
| (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate |
(5-甲基-2-氧代-1,3-二氧雜環(huán)戊烯-4-基)甲基 4-硝基苯基碳酸酯 |
173604-87-0 |
詳細(xì)
|
| Cabotegravir (GSK744, GSK1265744) |
卡博特韋 |
1051375-10-0 |
詳細(xì)
|
| biphenyl-2-yl-carbamic acid 1-[2-(benzylmethylamino)ethyl]piperidin-4-yl ester |
雷芬那辛中間體 |
864686-28-2 |
詳細(xì)
|
| Baloxavir |
巴洛沙韋 |
1985605-59-1 |
詳細(xì)
|
| (2S-trans)-3-Amino-2-methyl-4-oxoazetidine-1-sulphonic acid |
氨曲南主環(huán) |
80082-65-1 |
詳細(xì)
|
| 2-Mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate |
頭孢他啶側(cè)鏈酸活性酯 |
89604-92-2 |
詳細(xì)
|
| N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester |
雷芬那辛雜質(zhì)F |
1682660-39-4 |
詳細(xì)
|
| 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester |
加替環(huán)內(nèi)酯 |
112811-71-9 |
詳細(xì)
|
| Moxifloxacin hydrochloride |
鹽酸莫西沙星 |
186826-86-8 |
詳細(xì)
|
| 4-piperidyl N-(2-biphenyl)carbamate |
雷芬那辛 中間體 |
171722-92-2 |
詳細(xì)
|
| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)- |
非奈利酮雜質(zhì)J |
2640280-87-9 |
詳細(xì)
|
| Avibactam Sodium impurities G |
阿維巴坦鈉雜質(zhì)G，(2S,5R)-7-氧代-N-磺酸基-6-磺酸氧基-1,6-二氮雜雙環(huán)[3.2.1]辛烷-2-甲酰胺二鈉鹽 |
|
詳細(xì)
|
| Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- |
雷芬那辛雜質(zhì)A |
938143-02-3 |
詳細(xì)
|
| 5-deazaflavin |
脫氮黃素 |
26908-38-3 |
詳細(xì)
|
| Upadacitinib |
烏帕替尼 |
1310726-60-3 |
詳細(xì)
|
| Revefenacin |
雷芬那辛 |
864750-70-9 |
詳細(xì)
|
| Impurity A |
非奈利酮雜質(zhì)A |
2640280-82-4 |
詳細(xì)
|
| (2S,5R)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide 7-oxo-6-(sulfoxy)monosodium salt |
阿維巴坦鈉 |
1192491-61-4 |
詳細(xì)
|
| Ivabradine IMpurity |
伊伐布雷定雜質(zhì) |
1616710-50-9 |
詳細(xì)
|
| Finerenone (BAY 94-8862) |
非奈利酮 |
1050477-31-0 |
詳細(xì)
|
| 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
雷芬那辛 中間體 |
743460-48-2 |
詳細(xì)
|
| ZVPVPYWMFMUFEZ-UHFFFAOYSA-N |
1-(4-((2-(4-([1,1'-聯(lián)苯]-2-基氨甲酰)氧基)哌啶-1-基)乙基(甲基)氨甲酰)芐基)哌啶-4-羧酸 |
909800-36-8 |
詳細(xì)
|
| Rotigotine;;(6S)-6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol |
羅替戈??； (S)-5,6,7,8-四氫-6-(丙基(2-(2-噻吩基)乙基)氨基)-1-萘酚 |
99755-59-6 |
詳細(xì)
|
| 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl- |
非奈利酮雜質(zhì)K |
2084136-51-4 |
詳細(xì)
|
| 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl- |
非奈利酮雜質(zhì)E |
2640280-84-6 |
詳細(xì)
|
| vericiguat |
維利西呱 |
1350653-20-1 |
詳細(xì)
|
| 4,4'-Dimethylbiphenyl |
4,4'-二甲基聯(lián)苯 |
613-33-2 |
詳細(xì)
|
| 2-Benzoylpyrrole |
2-苯甲?；量?/td>
| 7697-46-3 |
詳細(xì)
|
| 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)- |
非奈利酮雜質(zhì)F |
2640280-85-7 |
詳細(xì)
|
| LeterMovir |
萊特莫韋 |
917389-32-3 |
詳細(xì)
|
| lifitegrast;;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6- carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic |
立他司特；；(S)-2-[2-(苯并呋喃-6-羰基)-5,7-二氯-1,2,3,4-四氫異喹啉-6-甲酰胺基]-3-(3-甲磺?；交?丙酸 |
1025967-78-5 |
詳細(xì)
|
| Larotrectinib |
硫酸拉羅替尼 |
1223405-08-0 |
詳細(xì)
|
| N-benzyl-2-chloro-N-methyl-ethanamine |
N-芐基-2-氯-N-甲基乙胺 |
17542-47-1 |
詳細(xì)
|
| 4-Benzoylmorpholine |
4-苯甲酰嗎啉 |
1468-28-6 |
詳細(xì)
|
| 2-(N-benzyl-N-methylamino)ethyl chloride hydrochloride |
N-(2-氯乙基)-N-甲基芐胺鹽酸鹽 |
23510-18-1 |
詳細(xì)
|
| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl- |
非奈利酮雜質(zhì)G |
2640280-86-8 |
詳細(xì)
|